Brief: Radiopharm Theranostics Reports FY Loss Attributable A$36.7 Million
29/08/2025 03:53
Aug 29 (Reuters) - Radiopharm Theranostics Ltd RAD.AX: FY REVENUE A$3.6 MILLION FY LOSS ATTRIBUTABLE A$36.7 MILLION Further company coverage: RAD.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Radiopharm Theranostics
See all newsNASDAQ RESUMED AT 09:47 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:42 AM
Brief: Radiopharm Theranostics To Meet With U.S. FDA To Align On Pivotal Phase 3 Trial Design For Rad 101 In Diagnosis Of Brain Metastases
NASDAQ RESUMED AT 09:56 AM
NASDAQ TRADE HALT CONTINUES VOLATILITY TRADING PAUSE AT 09:50 AM